Literature DB >> 12352923

The association of viral infection and chronic allograft nephropathy with graft dysfunction after renal transplantation.

C Y William Tong1, Ali Bakran, J S Malik Peiris, Peter Muir, C Simon Herrington.   

Abstract

BACKGROUND: The long-term effect of viral infections on graft dysfunction and rejection after renal transplantation is uncertain.
METHODS: A cohort of 37 renal transplant recipients was followed prospectively for 3 years. Creatinine clearance rate at 6 months and 3 years and chronic allograft nephropathy were correlated with the detection of cytomegalovirus (CMV), human herpesvirus 6 and human herpesvirus 7 and BK virus DNA, CMV disease, and acute rejection.
RESULTS: CMV disease was significantly associated with poor graft function at 6 months, whereas chronic allograft nephropathy was associated with graft dysfunction at 3 years. Both CMV disease and detection of human herpesvirus 6 DNA were associated with chronic allograft nephropathy.
CONCLUSIONS: CMV disease was a significant cause of early graft dysfunction, whereas the presence of chronic allograft nephropathy was the main determinant of poor long-term graft function. The role of viral infections in chronic allograft nephropathy deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12352923     DOI: 10.1097/00007890-200208270-00026

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  24 in total

1.  Adoptive T cell therapy for the treatment of viral infections.

Authors:  Reuben J Arasaratnam; Ann M Leen
Journal:  Ann Transl Med       Date:  2015-10

2.  Allograft rejection-related gene expression in the endothelial cells of renal transplantation recipients after cytomegalovirus infection.

Authors:  Yang Li; Hang Yan; Wu-jun Xue; Pu-xun Tian; Xiao-ming Ding; Xiao-ming Pan; Xin-shun Feng; Xiao-hui Tian; He-li Xiang; Jun Hou
Journal:  J Zhejiang Univ Sci B       Date:  2009-11       Impact factor: 3.066

3.  Subclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation.

Authors:  Jodi M Smith; Lawrence Corey; Rachel Bittner; Laura S Finn; Patrick J Healey; Connie L Davis; Ruth A McDonald
Journal:  J Am Soc Nephrol       Date:  2010-07-08       Impact factor: 10.121

4.  Ganciclovir transiently attenuates murine cytomegalovirus-associated renal allograft inflammation.

Authors:  Masako Shimamura; Ute Saunders; Brian Rha; Lingling Guo; Kevin A Cassady; James F George; William J Britt
Journal:  Transplantation       Date:  2011-10-15       Impact factor: 4.939

Review 5.  Combating chronic renal allograft dysfunction : optimal immunosuppressive regimens.

Authors:  Pierre Merville
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Prevalence and risk factors for early chronic allograft nephropathy in a live related renal transplant program.

Authors:  Hamid Khan; Muhammed Mubarak; Tahir Aziz; Ejaz Ahmed; Syed Fazal Akhter; Javed Kazi; Syed Aa Naqvi; Syed Ah Rizvi
Journal:  J Nephropathol       Date:  2014-04-01

Review 7.  Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.

Authors:  Daniel S Owers; Angela C Webster; Giovanni F M Strippoli; Kathy Kable; Elisabeth M Hodson
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

Review 8.  Kidney Fibrosis: Origins and Interventions.

Authors:  Thomas Vanhove; Roel Goldschmeding; Dirk Kuypers
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

9.  Cytomegalovirus-responsive γδ T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions.

Authors:  Thomas Bachelet; Lionel Couzi; Vincent Pitard; Xavier Sicard; Claire Rigothier; Sébastien Lepreux; Jean-François Moreau; Jean-Luc Taupin; Pierre Merville; Julie Déchanet-Merville
Journal:  J Am Soc Nephrol       Date:  2014-04-17       Impact factor: 10.121

Review 10.  Viral infection after renal transplantation: surveillance and management.

Authors:  Blair C Weikert; Emily A Blumberg
Journal:  Clin J Am Soc Nephrol       Date:  2008-03       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.